Notably, these results differ from previous studies using PDE10A inhibitors in lung and colon cancers, which concluded that cGMP/PKG signaling alone was responsible for growth inhibitory activity of PDE10A inhibitors [26, 27, 51]. Here, PRKG1 is linked to colonic neoplasm.